ShopSocially, a social commerce startup, is formally announcing the launch of its social shopping platform and is revealing some of its early insights from its customer lineup. The company has worked with several hundred customers to date, including big-name brands like Sears, The Children's Place, Sport Chalet, CafePress, Ritz, Zales and others. We've also learned that the company had quietly raised an angel round of $550,000 late last year through TiE Angels, which is in addition to the $1.1 million in funding from October 2010. Participating in the round were executives from Apple, Google, and Symantec, several VCs and TiE board members, however the individuals did not want their names disclosed at this time.
MLS games with 29 points on the season, while the Union is 0-4-1 with 8 points. The Union are have only won a single game at home this season, and it would be a great if they could win their second home match of the season against Kansas City.
Breaking News Saturday 23rd June, 2012
Our network flyer service provides a medium for putting your important news into a flyer on the web. Whether it be a new product launch, announcing a community event, promoting a Web site, or advertising your business, then our Network Flyers service is for you. Click here for more details
We've seen them holding hands and we've seen them embracing on the red carpet, but in Part 2 of her interview with Oprah Winfrey - airing this Sunday - Kim Kardashian admits verbally for the first time:
"I don't know why it took so long for us to kind of get together," Kardashian tells the ratings-challenged host, adding that she has no regrets over pretending to love marrying Kris Humphries. "I think I needed to go through all my experiences and some that he's gone through."
Kim also says the two have shared misery in common, with West's mother passing away in 2007 and Kim's dad dying of cancer in 2003.
"We've been friends for like six or seven years. So it's very comforting to have someone that knows everything about you, that respects you, understands [and] has gone through the similar things."
During the first part of Kim's interview with Oprah, she touched on the depression she experienced in the months following her divorce.
University of Nevada School of Medicine researcher reviews muscular dystrophy therapiesPublic release date: 21-Jun-2012 [ | E-mail | Share ]
Contact: Mike Wolterbeek mwolterbeek@unr.edu University of Nevada, Reno
'A Molecular Bandage for Diseased Muscle' appears today in prestigious Science publication
RENO, Nev. Leading muscular dystrophy researcher Dean Burkin, of the University of Nevada School of Medicine summarizes the impact of a new protein therapeutic, MG53, for the treatment of Duchenne muscular dystrophy in an article published this week in Science Translational Medicine.
"This is a focus article in which we summarize the impact of MG53 protein therapy as a treatment option and discuss the increasing number of new protein therapeutics being developed for the muscular dystrophies, including laminin-111 developed in our laboratory," Burkin, a pharmacological researcher and associate professor, said.
The article, "A Molecular Bandage for Diseased Muscle," co-authored by Ryan Wuebbles, a post-doctoral student in Burkin's lab in the University's Center for Molecular Medicine, is a review of the current status of therapeutic developments in the muscular dystrophy research field. These therapies represent significant strides and show great promise in treatment of muscular dystrophy.
Approaches to treat Duchenne muscular dystrophy include gene replacement therapy, gene repair and myoblast cell transfer.
In a study on MG53 by Noah Weislander and colleagues, presented in the same issue of Science Translational Medicine, it was found that mice that lack MG53 developed progressive muscle weakness and exhibit defective muscle repair after exercise or injury, and that MG53 facilitates rapid membrane repair to prevent damage to normal muscle.
The study suggests that treatment in combination with other protein therapies such as Burkin's laminin-111 therapy, are likely to have synergy as well for Duchenne and other muscular dystrophies.
Burkin's published research on laminin-111, a naturally occurring protein, showed it is quickly picked up in the bloodstream of mice and prevents muscle damage, an important finding for Duchenne muscular dystrophy, the most common form of muscular dystrophy.
He recently co-hosted Myomatrix 2012, a conference for leading muscular dystrophy scientists and clinicians to explore and share their latest findings and data on treatment breakthroughs. The conference was held at the University of Nevada, Reno campus, where research by Burkin has led to a potential new therapy for muscular dystrophy.
###
Burkin's work, which is funded by the National Institutes of Health, has also been featured on the website ScienCentral (www.sciencentral.com/video/2009/04/20/muscular-dystrophy-drug/). His work was published in the Proceedings of the National Academy of Sciences as well as the January 2009 edition of American Journal of Pathology.
For more information on Burkin and a link to his publications on PubMed visit http://www.medicine.nevada.edu/dept/pharmacology/faculty/burkin.html. The article by Burkin and Wuebbles can be found at http://stm.sciencemag.org/content/4/139/139fs19.full.
The weekly scientific journal Science Translational Medicine publishes papers that identify and fill scientific knowledge gaps at the junction of basic research and human applications.
Nevada's land-grant university founded in 1874, the University of Nevada, Reno has an enrollment of 18,000 students and is ranked in the top tier of the nation's best universities. Part of the Nevada System of Higher Education, the University has the system's largest research program and is home to the state's medical school. With outreach and education programs in all Nevada counties and with one of the nation's largest study-abroad consortiums, the University extends across the state and around the world. For more information, visit www.unr.edu.
[ | E-mail | Share ]
?
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.
University of Nevada School of Medicine researcher reviews muscular dystrophy therapiesPublic release date: 21-Jun-2012 [ | E-mail | Share ]
Contact: Mike Wolterbeek mwolterbeek@unr.edu University of Nevada, Reno
'A Molecular Bandage for Diseased Muscle' appears today in prestigious Science publication
RENO, Nev. Leading muscular dystrophy researcher Dean Burkin, of the University of Nevada School of Medicine summarizes the impact of a new protein therapeutic, MG53, for the treatment of Duchenne muscular dystrophy in an article published this week in Science Translational Medicine.
"This is a focus article in which we summarize the impact of MG53 protein therapy as a treatment option and discuss the increasing number of new protein therapeutics being developed for the muscular dystrophies, including laminin-111 developed in our laboratory," Burkin, a pharmacological researcher and associate professor, said.
The article, "A Molecular Bandage for Diseased Muscle," co-authored by Ryan Wuebbles, a post-doctoral student in Burkin's lab in the University's Center for Molecular Medicine, is a review of the current status of therapeutic developments in the muscular dystrophy research field. These therapies represent significant strides and show great promise in treatment of muscular dystrophy.
Approaches to treat Duchenne muscular dystrophy include gene replacement therapy, gene repair and myoblast cell transfer.
In a study on MG53 by Noah Weislander and colleagues, presented in the same issue of Science Translational Medicine, it was found that mice that lack MG53 developed progressive muscle weakness and exhibit defective muscle repair after exercise or injury, and that MG53 facilitates rapid membrane repair to prevent damage to normal muscle.
The study suggests that treatment in combination with other protein therapies such as Burkin's laminin-111 therapy, are likely to have synergy as well for Duchenne and other muscular dystrophies.
Burkin's published research on laminin-111, a naturally occurring protein, showed it is quickly picked up in the bloodstream of mice and prevents muscle damage, an important finding for Duchenne muscular dystrophy, the most common form of muscular dystrophy.
He recently co-hosted Myomatrix 2012, a conference for leading muscular dystrophy scientists and clinicians to explore and share their latest findings and data on treatment breakthroughs. The conference was held at the University of Nevada, Reno campus, where research by Burkin has led to a potential new therapy for muscular dystrophy.
###
Burkin's work, which is funded by the National Institutes of Health, has also been featured on the website ScienCentral (www.sciencentral.com/video/2009/04/20/muscular-dystrophy-drug/). His work was published in the Proceedings of the National Academy of Sciences as well as the January 2009 edition of American Journal of Pathology.
For more information on Burkin and a link to his publications on PubMed visit http://www.medicine.nevada.edu/dept/pharmacology/faculty/burkin.html. The article by Burkin and Wuebbles can be found at http://stm.sciencemag.org/content/4/139/139fs19.full.
The weekly scientific journal Science Translational Medicine publishes papers that identify and fill scientific knowledge gaps at the junction of basic research and human applications.
Nevada's land-grant university founded in 1874, the University of Nevada, Reno has an enrollment of 18,000 students and is ranked in the top tier of the nation's best universities. Part of the Nevada System of Higher Education, the University has the system's largest research program and is home to the state's medical school. With outreach and education programs in all Nevada counties and with one of the nation's largest study-abroad consortiums, the University extends across the state and around the world. For more information, visit www.unr.edu.
[ | E-mail | Share ]
?
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.
?How to connect flash drives, hard drives, keyboards and mice to the Samsung Galaxy S III using USB host
Here's a lesser-known feature of the new Galaxy S III -- the ability to connect all manner of USB peripherals to Samsung's latest flagship phone, from mass storage to input devices. You'll need a USB OTG (on-the-go) cable to be able to connect all this stuff into the Galaxy S III or any other USB host-supporting phone.
Like the Galaxy S II and Galaxy Note before it, the S III supports full USB host capabilities, meaning if you've got the right connector you can go completely nuts and plug all sorts of stuff into the phone. In our video, we tried USB memory sticks, full-sized SD card readers, USB hubs, hard drives, keyboards and mice. All of them worked. At one point we even had a hub plugged into the S III, allowing keyboard and mouse support simultaneously.
While we don't imagine many people will be using this feature every day, it's certainly impressive to see a smartphone able to handle such a wide range of USB gadgets, including full-sized desktop peripherals. Check out our video demo of USB host on the Samsung Galaxy S III above, and be sure to share your own experiences down in the comments if you've tinkered with this sort of thing yourself.
FILE - In this February 23, 2012 file photo, Secretary of Commerce John Bryson speaks about privacy at the Eisenhower Executive Office Building in Washington. Bryson says he is resigning after suffering a seizure earlier this month in the Los Angeles area. (AP Photo/Manuel Balce Ceneta)
FILE - In this February 23, 2012 file photo, Secretary of Commerce John Bryson speaks about privacy at the Eisenhower Executive Office Building in Washington. Bryson says he is resigning after suffering a seizure earlier this month in the Los Angeles area. (AP Photo/Manuel Balce Ceneta)
WASHINGTON (AP) ? Commerce Secretary John Bryson said Thursday he is resigning from the Obama administration after suffering a seizure earlier this month in the Los Angeles area.
President Barack Obama said in a statement that he had accepted the resignation and thanked Bryson for the "invaluable experience and expertise" he brought to the administration.
Bryson, a 68-year-old former utility executive, served as a member of Obama's economic team and has advised the president on energy issues. He made his resignation official in a letter to Obama, dated Wednesday, and said it was a "consequence of a recent seizure and a medical leave of absence."
"I have concluded that the seizure I suffered on June 9th could be a distraction from my performance as secretary, and that our country would be better served by a change in leadership," Bryson wrote.
His resignation followed a series of traffic incidents in California earlier this month. Authorities said Bryson was driving alone in a Lexus near Los Angeles when he struck a vehicle that had stopped for a passing train. He spoke briefly with the three occupants, and then hit their car again as he departed.
The secretary then struck a second car in a nearby city, where he was later found unconscious in his car. Bryson took a Breathalyzer test that didn't detect any alcohol, authorities said.
Commerce officials said Bryson had not suffered a seizure previously and had "limited recall of the event" involved in the crashes.
In a separate message to Commerce Department employees on Thursday morning, Bryson said their efforts to help American businesses "build our economy and create jobs is more important now than ever." Obama is in the midst of an intense re-election race that will largely be determined by the fate of the economy.
The White House said Obama would meet with Bryson Thursday afternoon in the Oval Office to thank him for his service.
Bryson said he would keep supporting Obama in a "personal capacity." The White House statement did not immediately offer details about Obama's plan to find a permanent successor.
Earlier this month, Bryson transferred his functions and duties as secretary to Deputy Secretary Rebecca Blank, who is now acting commerce secretary. The president expressed confidence in Blank's ability to run the department, saying the staff would continue "putting forward policies that help our workers and businesses compete."
Shortly after word of the resignation Thursday, Los Angeles County district attorney's spokeswoman Jane Robison said that the district attorney's office has not been presented any case for review. She said the incident remains under investigation by the original law enforcement agency, the San Gabriel Police Department.
The commerce secretary post, typically a low-profile cabinet position, has been problematic for Obama since his first weeks in office.
Obama's first pick to run the department, former New Mexico Gov. Bill Richardson, withdrew from consideration because of a federal investigation into how his political donors won contracts in the state. Obama then nominated New Hampshire Republican Sen. Judd Gregg, but he also withdrew, saying he realized he had "irresolvable conflicts" with the president's economic policies.
The president finally found success with Gary Locke, the former Washington state governor. Locke served as secretary until 2011, when Obama asked him to move to China to become the U.S. ambassador. Obama then tapped Bryson to fill the post.
___
Associated Press writer John Antczak in Los Angeles contributed to this report.
ShopSocially, a social commerce startup, is formally announcing the launch of its social shopping platform and is revealing some of its early insights from its customer lineup. The company has worked with several hundred customers to date, including big-name brands like Sears, The Children's Place, Sport Chalet, CafePress, Ritz, Zales and others. We've also learned that the company had quietly raised an angel round of $550,000 late last year through TiE Angels, which is in addition to the $1.1 million in funding from October 2010. Participating in the round were executives from Apple, Google, and Symantec, several VCs and TiE board members, however the individuals did not want their names disclosed at this time.
![[ Back to EurekAlert! ]](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_unXGlmCM5lINHMHsB1Y9DeVyB17cKIExzeM19Pvv-IptaTRLz_8tGP2QMJCQqNxq9tbB5baUy02P6Dj9mofm13WqMD8vYfxbHdGyDZoBY=s0-d){kind=small}
Public release date: 21-Jun-2012
Share ] 
